tailieunhanh - A reprint from American Scientist the magazine of Sigma Xi, The Scientific Research Society

A variety of occupational risks is known to cause cancer. Every year more than seven million people die of cancer. Forty percent of these cases could be prevented which means that one in every ten cancer deaths is preventable through interventions targeted on exposure in the working environment. The articles in this issue of GOHNET highlight some aspects of the problem and the prevention of occupational cancer. The articles draw your attention to the large number of workers exposed to specific carcinogens such as asbestos, UV radiation, tobacco smoke, as well as to those workers engaged in occupations and. | A reprint from American Scientist the magazine of Sigma Xi The Scientific Research Society This reprint is provided for personal and noncommercial use. For any other use please send a request to Permissions American Scientist . Box 13975 Research Triangle Park NC 27709 . or by electronic mail to perms@. Sigma Xi The Scientific Research Society and other rightsholders Fallout from Nuclear Weapons Tests and Cancer Risks Exposures 50 years ago still have health implications today that will continue into the future Steven L. Simon André Bouville and Charles E. Land Prior to 1950 only limited consideration was given to the health impacts of worldwide dispersion of radioactivity from nuclear testing. But in the following decade humanity began to significantly change the global radiation environment by testing nuclear Steven L. Simon received a . in radiological health sciences from Colorado State University in 1985. He has served on the faculties of the University of Utah and the University of North Carolina at Chapel Hill. He spent five years directing the Marshall Islands Nationwide Radiological Study and also participated in the radiological monitoring of the former nuclear test sites at Johnston Island in Algeria and in French Polynesia. Simon joined the National Cancer Institute NCI in 2000 and now focuses on retrospective dose estimation in support of epidemiologic studies of radioactive fallout and occupational exposure in medicine. André Bouville was born in France and obtained his . in physics at the Université Paul-Sabatier in Toulouse in 1970. He served as a consultant to the United Scientific Committee on the Effects of Atomic Radiationfor 30 years and the International Commission on Radiological Protection ICRP for 17 years. Bouville joined the National Cancer Institute in 1984 and has since been heavily involved in the estimation of radiation doses resulting from radioactive fallout from atmospheric nuclear weapons tests and from .

• Y học thường thức
• Newly Diagnosed
• Thromboprophylaxis
• Venous Thrombosis
• Special Considerations
• Venous Thromboembolism
• Cancer Patient
• Drug resistance
• NAT2 polymorphism
• Newly diagnosed TB
• Recurrent TB1
• NAT2 gene polymorphism
• Prevalence of HCV infection
• HCV infection
• Newly diagnosed HIV patients
• Seroprevalence of HCV infection
• Cross sectional
• BMC Cancer
• Bone marrow involvement
• Bone marrow biopsy
• Diagnosed lymphomas
• Iliac crest biopsy
• BMC Pulmonary Medicine
• Decision making process
• Thin section CT
• Thoracic surgery
• Diagnosed lung cancer
• Randomized controlled trial
• Short course radiotherapy
• Diagnosed glioblastoma
• Overall survival
• Pelvic Floor Symptoms
• Epidemiology
• New Models
• 3D Culture Systems
• Role of Bioreactors
• Báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• báo cáo hóa học
• công trình nghiên cứu về hóa học
• tài liệu về hóa học
• Antidepressants and Morphological
• Monoamine Neurons
• Guri Rortveit
• Multi Disciplinary
• Diagnosis and Treatment
• Urinary Incontinence
• BMC Pediatrics
• Diabetes education
• Qualitative research
• Type 1 diabetes
• Mol’s philosophical theory
• Type 2 diabetes mellitus
• Fatty liver
• Alanine aminotransferase
• Aspartate aminotransferase
• Celiac disease
• Fat soluble vitamins
• Helicobacter pylori
• Hyperparathyroidism findings
• Ewing sarcoma
• Event free survival
• Cytosine arabinoside
• Langerhans cell histiocytosis
• Hematological adverse
• Multiple myeloma
• Bone disease
• Physical function
• Reference values
• Colorectal cancer
• Bone metastasis
• Risk model
• Risk factors
• The surveillance
• Autologous stem cell transplant
• High dose chemotherapy
• Duration of response
• Chronic myeloid leukemia
• Network meta analysis
• Tyrosine kinase inhibitors
• Chronic phase chronic myeloid leukemia
• Richter syndrome
• Richter transformation
• BTK inhibitor
• Chronic lymphocytic leukaemia
• Palliative care
• Early integrated care
• Quality of life research
• Randomized clinical trial
• Cost effectiveness
• Platelet recovery
• Prognostic indicator
• Acute myeloid leukaemia
• Definite prognostic clinical factors
• Hepatitis B
• Hepatocellular carcinoma
• Late presentation
• Outpatient clinic visits